Calcineurin mediates AKT dephosphorylation in the ischemic rat retina

Chang Hwan Park1, Yoon Sook Kim, Young Hee Kim

  • 1Department of Anatomy, School of Medicine, Institute of Health Sciences, Medical Research Center for Neural Dysfunction, Gyeongsang National University, 92 Chilam-dong, Jinju, Gyeongnam 660-751, South Korea.

Brain Research
|August 16, 2008
PubMed

Insights

Calcineurin (CaN) cleavage reduces Akt phosphorylation and promotes retinal cell apoptosis during ischemic injury. Inhibiting CaN with FK506 reduces this dephosphorylation and protects neurons.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Calcineurin (CaN) is a calcium/calmodulin-dependent protein phosphatase implicated in apoptosis.
  • Akt (protein kinase B) regulates cell death and survival pathways, activated by phosphorylation.
  • The interplay between CaN and Akt during ischemic injury is not fully understood.

Purpose of the Study:

  • To investigate CaN's role in neuronal apoptosis and Akt dephosphorylation following transient ischemia.
  • To examine the interdependence of CaN and Akt/PKB in the rat retina post-ischemia.

Main Methods:

  • Transient ischemia was induced in rat retinas.
  • Levels of CaN, Akt, and Bad were analyzed with and without FK506 (CaN inhibitor).
  • TUNEL assay was used to quantify neuronal apoptosis.

Main Results:

  • CaN cleavage reduced Akt phosphorylation at Thr308 and Ser473, promoting apoptosis via Bad dephosphorylation.
  • FK506 treatment significantly reduced Akt and Bad dephosphorylation.
  • Intravitreal FK506 injection decreased TUNEL-positive neurons after transient ischemia.

Conclusions:

  • CaN cleavage negatively regulates Akt phosphorylation during ischemic injury.
  • CaN plays a critical role in retinal cell apoptosis following transient ischemia.
  • Inhibition of CaN may offer a neuroprotective strategy against ischemic damage.

Related Concept Videos